CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-08 | Humeau Laurent Chief Scientific Officer | Grant or award · Common Stock Option | +93,200 | 93,200 | ||
| 2019-03-08 | Humeau Laurent Chief Scientific Officer | Grant or award · Restricted Stock Unit | +59,700 | 59,700 | ||
| 2019-03-08 | Kim Jong Joseph Chief Executive Officer | Grant or award · Common Stock Option | +298,100 | 298,100 | ||
| 2019-03-08 | Kim Jong Joseph Chief Executive Officer | Grant or award · Restricted Stock Unit | +191,100 | 191,100 | ||
| 2019-03-08 | KIES PETER CFO | Grant or award · Common Stock Option | +100,500 | 100,500 | ||
| 2019-03-08 | KIES PETER CFO | Grant or award · Restricted Stock Unit | +64,400 | 64,400 | ||
| 2019-03-08 | Weiner David B. Director | Grant or award · Common Stock Option | +60,000 | 60,000 | ||
| 2019-03-08 | Weiner David B. Director | Grant or award · Restricted Stock Unit | +35,000 | 35,000 | ||
| 2019-03-05 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion | +27,567 | 109,080 | ||
| 2019-03-05 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −8,408 | $3.61 | $30K | 100,672 |
| 2019-03-05 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −27,567 | 55,133 | ||
| 2019-03-05 | Weiner David B. Director | Exercise or conversion | +11,667 | 778,292 | ||
| 2019-03-05 | Weiner David B. Director | Exercise or conversion · Restricted Stock Unit | −11,667 | 23,333 | ||
| 2019-03-05 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +120,100 | 2,428,594 | ||
| 2019-03-05 | Kim Jong Joseph Chief Executive Officer | Shares withheld for taxes | −34,139 | $3.61 | $123K | 2,394,455 |
| 2019-03-05 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −120,100 | 240,200 | ||
| 2019-03-05 | KIES PETER CFO | Exercise or conversion | +27,567 | 89,655 | ||
| 2019-03-05 | KIES PETER CFO | Shares withheld for taxes | −10,301 | $3.61 | $37K | 79,354 |
| 2019-03-05 | KIES PETER CFO | Exercise or conversion · Restricted Stock Unit | −27,567 | 55,133 | ||
| 2019-01-03 | Zoth Lota S. Director | Grant or award · Common Stock Option | +20,000 | 20,000 |
Page 37 of 49 · 961 trades